SYNLOGIC, INC. Operating Cash Flow
SYNLOGIC, INC. (SYBX) reported Operating Cash Flow of -$1.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- SYNLOGIC, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$922.00K.
- SYNLOGIC, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$563.00K.
- SYNLOGIC, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$923.00K.
- SYNLOGIC, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.44M.
- SYNLOGIC, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$4.36M.
- SYNLOGIC, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$31.66M.
- SYNLOGIC, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$51.61M.
- SYNLOGIC, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$56.89M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$922.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.49M 10-Q · filed 2026-08-11 | -$2.41M derived: sum of 3 quarters · filed 2026-08-11 | -$3.84M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | -$563.00K 10-Q · filed 2026-05-14 | -$1.49M derived: sum of 2 quarters · filed 2026-05-14 | -$2.92M derived: sum of 3 quarters · filed 2026-05-14 | -$3.32M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | -$923.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$2.36M derived: sum of 2 quarters · filed 2026-03-12 | -$2.76M derived: sum of 3 quarters · filed 2026-08-11 | -$4.36M 10-K · filed 2026-03-12 | |
| 2025-09-30 | -$1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.83M derived: sum of 2 quarters · filed 2026-08-11 | -$3.44M 10-Q · filed 2025-11-13 | -$4.00M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | -$399.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$2.00M 10-Q · filed 2026-08-11 | -$2.57M derived: sum of 3 quarters · filed 2026-08-11 | -$3.22M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | -$1.60M 10-Q · filed 2026-05-14 | -$2.17M derived: sum of 2 quarters · filed 2026-05-14 | -$2.82M derived: sum of 3 quarters · filed 2026-05-14 | -$17.82M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$568.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.22M derived: sum of 2 quarters · filed 2026-03-12 | -$16.22M derived: sum of 3 quarters · filed 2026-03-12 | -$31.66M 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$648.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$15.65M derived: sum of 2 quarters · filed 2025-11-13 | -$31.09M 10-Q · filed 2025-11-13 | -$36.62M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$15.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$30.44M 10-Q · filed 2025-08-07 | -$30.44M 10-Q · filed 2024-08-08 | -$35.97M derived: sum of 3 quarters · filed 2025-08-07 | -$48.92M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$15.44M 10-Q · filed 2025-05-08 | -$20.96M derived: sum of 2 quarters · filed 2025-05-08 | -$33.92M derived: sum of 3 quarters · filed 2025-05-08 | -$45.55M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$18.48M derived: sum of 2 quarters · filed 2025-03-06 | -$30.11M derived: sum of 3 quarters · filed 2025-03-06 | -$51.61M 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$12.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$24.58M derived: sum of 2 quarters · filed 2024-11-12 | -$46.09M 10-Q · filed 2024-11-12 | -$58.48M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$11.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$33.13M 10-Q · filed 2024-08-08 | -$45.52M derived: sum of 3 quarters · filed 2024-08-08 | -$60.97M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$21.50M 10-Q · filed 2024-05-14 | -$33.90M derived: sum of 2 quarters · filed 2024-05-14 | -$49.35M derived: sum of 3 quarters · filed 2024-05-14 | -$62.92M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$12.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$27.84M derived: sum of 2 quarters · filed 2024-03-19 | -$41.41M derived: sum of 3 quarters · filed 2024-03-19 | -$56.89M 10-K · filed 2024-03-19 | |
| 2022-09-30 | -$15.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$29.02M derived: sum of 2 quarters · filed 2023-11-09 | -$44.49M 10-Q · filed 2023-11-09 | -$57.55M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$13.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$29.05M 10-Q · filed 2023-08-10 | -$42.11M derived: sum of 3 quarters · filed 2023-08-10 | -$55.92M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$15.48M 10-Q · filed 2023-05-11 | -$28.54M derived: sum of 2 quarters · filed 2023-05-11 | -$42.35M derived: sum of 3 quarters · filed 2023-05-11 | -$53.70M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$13.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$26.88M derived: sum of 2 quarters · filed 2023-03-29 | -$38.22M derived: sum of 3 quarters · filed 2023-03-29 | -$52.20M 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$13.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$25.16M derived: sum of 2 quarters · filed 2022-11-10 | -$39.14M 10-Q · filed 2022-11-10 | -$49.03M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$11.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$25.32M 10-Q · filed 2022-08-11 | -$35.21M derived: sum of 3 quarters · filed 2022-08-11 | -$43.41M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$13.98M 10-Q · filed 2022-05-12 | -$23.86M derived: sum of 2 quarters · filed 2022-05-12 | -$32.06M derived: sum of 3 quarters · filed 2022-05-12 | -$41.05M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$9.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$18.09M derived: sum of 2 quarters · filed 2022-03-17 | -$27.07M derived: sum of 3 quarters · filed 2022-03-17 | -$39.55M 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$8.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$17.19M derived: sum of 2 quarters · filed 2021-11-10 | -$29.66M 10-Q · filed 2021-11-10 | -$40.88M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$8.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$21.47M 10-Q · filed 2021-08-12 | -$32.68M derived: sum of 3 quarters · filed 2021-08-12 | -$43.23M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$12.48M 10-Q · filed 2021-05-13 | -$23.69M derived: sum of 2 quarters · filed 2021-05-13 | -$34.24M derived: sum of 3 quarters · filed 2021-05-13 | -$74.83M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | -$11.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$21.76M derived: sum of 2 quarters · filed 2021-03-25 | -$62.35M derived: sum of 3 quarters · filed 2021-03-25 | -$75.47M 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$10.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$51.14M derived: sum of 2 quarters · filed 2020-11-05 | -$64.25M 10-Q · filed 2020-11-05 | -$73.22M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | -$40.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$53.70M 10-Q · filed 2020-08-06 | -$62.67M derived: sum of 3 quarters · filed 2020-08-06 | -$72.34M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | -$13.12M 10-Q · filed 2020-05-08 | -$22.08M derived: sum of 2 quarters · filed 2020-05-08 | -$31.75M derived: sum of 3 quarters · filed 2020-05-08 | -$42.56M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-12-31 | -$8.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$18.64M derived: sum of 2 quarters · filed 2020-03-12 | -$29.44M derived: sum of 3 quarters · filed 2020-03-12 | -$42.47M 10-K · filed 2020-03-12 | |
| 2018-09-30 | -$9.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$20.48M derived: sum of 2 quarters · filed 2019-11-12 | -$33.51M 10-Q · filed 2019-11-12 | -$42.53M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | -$10.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$23.84M 10-Q · filed 2019-08-08 | -$32.86M derived: sum of 3 quarters · filed 2019-08-08 | -$40.35M derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | -$13.03M 10-Q · filed 2019-05-09 | -$22.05M derived: sum of 2 quarters · filed 2019-05-09 | -$29.55M derived: sum of 3 quarters · filed 2019-05-09 | -$40.87M derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | -$9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$16.52M derived: sum of 2 quarters · filed 2019-03-12 | -$27.84M derived: sum of 3 quarters · filed 2019-03-12 | -$31.05M 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$7.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$18.82M derived: sum of 2 quarters · filed 2018-11-13 | -$22.03M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$11.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$14.54M 10-Q · filed 2018-08-09 | -$15.42M 10-Q · filed 2017-08-04 | ||
| 2017-03-31 | -$3.22M 10-Q · filed 2017-05-09 | ||||
| 2016-09-30 | $266.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$4.86M derived: sum of 2 quarters · filed 2017-11-13 | -$13.83M 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | -$5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$14.10M 10-Q · filed 2017-08-04 | |||
| 2016-03-31 | -$8.97M 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |